Medigene AG (MDG1) — Tangible Net Worth Ratio
Medigene AG (MDG1) has a Tangible Net Worth Ratio of 50.0% as of June 2024. This metric is calculated by deducting intangible assets (€9.84 Million) from net assets (€19.66 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Medigene AG to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medigene AG Tangible Net Worth Ratio (2006–2023)
This chart shows how Medigene AG's Tangible Net Worth Ratio has changed across 18 annual periods from 2006 to 2023. As of June 2024, the ratio stands at 50.0%, reflecting net assets of €19.66 Million with intangible assets of €9.84 Million EUR. See MDG1 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Medigene AG (2006–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Medigene AG from 2006 to 2023, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see MDG1 market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 53.2% | €21.07 Million | €9.85 Million | €31.72 Million | ▼ -20.4 pp |
| 2022 | 73.7% | €37.03 Million | €9.75 Million | €51.68 Million | ▲ +40.9 pp |
| 2021 | 32.8% | €44.82 Million | €30.11 Million | €59.47 Million | ▼ -7.7 pp |
| 2020 | 40.5% | €53.15 Million | €31.63 Million | €74.75 Million | ▼ -18.6 pp |
| 2019 | 59.1% | €81.82 Million | €33.49 Million | €109.22 Million | ▼ -9.3 pp |
| 2018 | 68.3% | €107.42 Million | €34.01 Million | €129.59 Million | ▲ +7.9 pp |
| 2017 | 60.4% | €86.17 Million | €34.08 Million | €111.94 Million | ▲ +3.1 pp |
| 2016 | 57.3% | €78.59 Million | €33.55 Million | €111.72 Million | ▼ -5.5 pp |
| 2015 | 62.8% | €89.99 Million | €33.50 Million | €113.53 Million | ▲ +36.5 pp |
| 2014 | 26.3% | €49.07 Million | €36.16 Million | €71.28 Million | ▲ +0.6 pp |
| 2013 | 25.7% | €36.28 Million | €26.96 Million | €52.66 Million | ▼ -12.4 pp |
| 2012 | 38.1% | €44.22 Million | €27.37 Million | €61.26 Million | ▼ -4.1 pp |
| 2011 | 42.2% | €47.93 Million | €27.73 Million | €53.29 Million | ▲ +20.3 pp |
| 2010 | 21.8% | €40.80 Million | €31.89 Million | €58.20 Million | ▼ -19.4 pp |
| 2009 | 41.2% | €51.87 Million | €30.50 Million | €65.72 Million | ▼ -14.9 pp |
| 2008 | 56.1% | €64.91 Million | €28.51 Million | €80.75 Million | ▼ -43.9 pp |
| 2007 | 100.0% | €103.09 Million | €0.00 | €114.93 Million | ▲ +0.0 pp |
| 2006 | 100.0% | €108.51 Million | €0.00 | €124.14 Million | — |